Evidence map›Paper›PMID 35817871›Full record

ArticleNature structural & molecular biology2022

Structural insight into apelin receptor-G protein stoichiometry.

Yang Yue, Lier Liu, Li-Jie Wu, Yiran Wu, Ling Wang, Fei Li, Junlin Liu, Gye-Won Han, Bo Chen, Xi Lin and 9 more

Abstract read
PubMed Publisher
In one paragraph

Article in Nature structural & molecular biology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 36 papers.

0numbers the graph read from it
0cells of the map it votes in
36citing papers in PubMed
10.6field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

36 citing papers in PubMed, 64 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. GPCR Heterodimers: Implications for Biased Signaling.Handbook of experimental pharmacology · 2026
    Review
  9. Article
  10. Review
  11. Article
  12. Article
  13. State-Specific Peptide Design Targeting G Protein-Coupled Receptors.Journal of chemical information and modeling · 2025
    Article
  14. A biased allosteric modulator functions as a molecular glue to induce βbioRxiv : the preprint server for biology · 2025
    Article
  15. Stabilized DNature communications · 2025
    Article
  16. Review
  17. Article
  18. Article
  19. Article
  20. Multiscale biased chemical space remodeling for developing APLNR agonists with anti-HFpEF efficacy.Proceedings of the National Academy of Sciences of the United States of America · 2025
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

19 authors at 4 institutions in 3 countries.

Yang Yue *iHuman Institute, ShanghaiTech University, Shanghai, China.
Lier Liu *iHuman Institute, ShanghaiTech University, Shanghai, China.
Li-Jie Wu *iHuman Institute, ShanghaiTech University, Shanghai, China.ORCID http://orcid.org/0000-0002-2253-0497
Yiran WuiHuman Institute, ShanghaiTech University, Shanghai, China.ORCID http://orcid.org/0000-0001-6790-7473
Ling WangiHuman Institute, ShanghaiTech University, Shanghai, China.
Fei LiiHuman Institute, ShanghaiTech University, Shanghai, China.
Junlin LiuiHuman Institute, ShanghaiTech University, Shanghai, China.
Gye-Won HanDepartments of Biological Sciences and Chemistry, Bridge Institute, University of Southern California, Los Angeles, CA, USA.
Bo CheniHuman Institute, ShanghaiTech University, Shanghai, China.
Xi LiniHuman Institute, ShanghaiTech University, Shanghai, China.ORCID http://orcid.org/0000-0002-9712-1882
Rebecca L BrouilletteDepartment of Pharmacology-Physiology, Faculty of Medicine and Health Sciences, Institute of Pharmacology at Sherbrooke, University of Sherbrooke, Sherbrooke, Quebec, Canada.ORCID http://orcid.org/0000-0002-5466-9653
Émile BreaultDepartment of Pharmacology-Physiology, Faculty of Medicine and Health Sciences, Institute of Pharmacology at Sherbrooke, University of Sherbrooke, Sherbrooke, Quebec, Canada.ORCID http://orcid.org/0000-0002-1937-450X
Jean-Michel LongpréDepartment of Pharmacology-Physiology, Faculty of Medicine and Health Sciences, Institute of Pharmacology at Sherbrooke, University of Sherbrooke, Sherbrooke, Quebec, Canada.ORCID http://orcid.org/0000-0003-3985-2318
Songting ShiStructure Therapeutics, South San Francisco, CA, USA.
Hui LeiStructure Therapeutics, South San Francisco, CA, USA.
Philippe SarretDepartment of Pharmacology-Physiology, Faculty of Medicine and Health Sciences, Institute of Pharmacology at Sherbrooke, University of Sherbrooke, Sherbrooke, Quebec, Canada.ORCID http://orcid.org/0000-0002-7627-701X
Raymond C StevensiHuman Institute, ShanghaiTech University, Shanghai, China.
Michael A HansonStructure Therapeutics, South San Francisco, CA, USA.
Fei XuiHuman Institute, ShanghaiTech University, Shanghai, China. xufei@shanghaitech.edu.cn.ORCID http://orcid.org/0000-0003-0719-3901
ShanghaiTech University · CNUniversité de Sherbrooke · CARapt Therapeutics (United States) · USUniversity of Southern California · US

Funding

CIHR FDN-148413
6 · The paper itself

Abstract

The technique of cryogenic-electron microscopy (cryo-EM) has revolutionized the field of membrane protein structure and function with a focus on the dominantly observed molecular species. This report describes the structural characterization of a fully active human apelin receptor (APJR) complexed with heterotrimeric G protein observed in both 2:1 and 1:1 stoichiometric ratios. We use cryo-EM single-particle analysis to determine the structural details of both species from the same sample preparation. Protein preparations, in the presence of the endogenous peptide ligand ELA or a synthetic small molecule, both demonstrate these mixed stoichiometric states. Structural differences in G protein engagement between dimeric and monomeric APJR suggest a role for the stoichiometry of G protein-coupled receptor- (GPCR-)G protein coupling on downstream signaling and receptor pharmacology. Furthermore, a small, hydrophobic dimer interface provides a starting framework for additional class A GPCR dimerization studies. Together, these findings uncover a mechanism of versatile regulation through oligomerization by which GPCRs can modulate their signaling.

Indexed as

GTP-Binding ProteinsReceptors, G-Protein-CoupledApelin ReceptorsCarrier ProteinsHumansSignal TransductionApelin ReceptorsCarrier ProteinsGTP-Binding ProteinsReceptors, G-Protein-Coupled

Identifiers

PMID35817871
OpenAlexW4285004613

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.